Metastasis: New perspectives on an old problem

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Kraljevic Pavelic, Sandra ^a   Sedic, Mirela ^b   Bosnjak, Hrvojka ^c   Spaventi, Sime ^d   Pavelic, Kresimir ^a  

^a Centre for High throughput Technologies Radmile Matej i 2   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^d CROATIAN ACADEMY OF SCIENCES AND ARTS   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CD123 ANTIGEN; CD133 ANTIGEN; CD19 ANTIGEN; CD24 ANTIGEN; CD34 ANTIBODY; CD38 ANTIGEN; CD39 ANTIGEN; CELL SURFACE MARKER; CELL SURFACE RECEPTOR; CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; CONNECTIVE TISSUE GROWTH FACTOR; CYCLOOXYGENASE 2; CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HEAT SHOCK PROTEIN 27; HERMES ANTIGEN; INTERLEUKIN 11; INTERSTITIAL COLLAGENASE; OSTEOPONTIN; PACLITAXEL; PROTEOME; RANTES; SMAD4 PROTEIN; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNINDEXED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANAPLASTIC EPENDYMOMA; B ACUTE LYMPHOGENOUS LEUKEMIA; BLAST CELL CRISIS; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GENETICS; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER STEM CELL; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM TUMOR; CHRONIC MYELOID LEUKEMIA; COLON CANCER; COLORECTAL CANCER; DISTANT METASTASIS; EMBRYONIC STEM CELL; FUNCTIONAL PROTEOMICS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE MAPPING; GLIOBLASTOMA; HEAD AND NECK CARCINOMA; HUMAN; KIDNEY METASTASIS; LASER CAPTURE MICRODISSECTION; LIVER CANCER; LIVER CELL; LIVER CELL CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MACROMETASTASIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDULLOBLASTOMA; MELANOMA; METABOLOMICS; METASTASIS; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; MUTATION RATE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; OSTEOSARCOMA; OVARY CANCER; PANCREAS CANCER; PH1 ACUTE LYMPHOGENOUS LEUKEMIA; PILOCYTIC ASTROCYTOMA; PRIMARY TUMOR; PROSTATE CANCER; PROSTATE CARCINOMA; PROTEIN MICROARRAY; PROTEOMICS; REVIEW; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TUMOR GENE; TWO DIMENSIONAL GEL ELECTROPHORESIS; ANIMAL; BIOLOGICAL MODEL; GENETICS; PATHOLOGY; TROPISM;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; PROTEOMICS; TROPISM;

EID: 79951798883     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-22     Document Type: Review

References (101)

1. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511. 10.1038/35000501, 10676951.
2. Chung CH, Bernard PS, Perou CM. Molecular portraits and the family tree of cancer. Nat Genet 2002, 32(Suppl):533-540. 10.1038/ng1038, 12454650.
3. Staudt LM. Gene expression profiling of lymphoid malignancies. Annu Rev Med 2002, 53:303-318. 10.1146/annurev.med.53.082901.103941, 11818476.
4. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
5. Schulenburg A, Bramswig K, Herrmann H, Karlic H, Mirkina I, Hubmann R, Laffer S, Marian B, Shehata M, Krepler C, Pehamberger H, Grunt T, Jager U, Zielinski CC, Valent P. Neoplastic stem cells: current concepts and clinical perspectives. Crit Rev Oncol Hematol 76:79-98. 10.1016/j.critrevonc.2010.01.001, 20185329.
6. Kitamura H, Okudela K, Yazawa T, Sato H, Shimoyamada H. Cancer stem cell: implications in cancer biology and therapy with special reference to lung cancer. Lung Cancer 2009, 66:275-281. 10.1016/j.lungcan.2009.07.019, 19716622.
7. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111. 10.1038/35102167, 11689955.
8. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea--a paradigm shift. Cancer Res 2006, 66:1883-1890. discussion 1895-1886, 10.1158/0008-5472.CAN-05-3153, 16488983.
9. Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, Tan LK, Rosen JM, Varmus HE. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA 2003, 100:15853-15858. 10.1073/pnas.2136825100, 307657, 14668450.
10. Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, Smid M, Foekens JA, Massague J. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 2009, 16:67-78. 10.1016/j.ccr.2009.05.017, 2749247, 19573813.
11. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet 2007, 8:341-352. 10.1038/nrg2101, 17440531.
12. Madani I, De Neve W, Mareel M. Does ionizing radiation stimulate cancer invasion and metastasis?. Bull Cancer 2008, 95:292-300.
13. Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, Doiphode RY, Bapat SA. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 2009, 27:2059-2068. 10.1002/stem.154, 19544473.
14. Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y, Noguchi S. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res 2009, 15:4234-4241. 10.1158/1078-0432.CCR-08-1479, 19509181.
15. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005, 5:275-284. 10.1038/nrc1590, 15803154.
16. Gray JW. Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors. Cancer Cell 2003, 4:4-6. 10.1016/S1535-6108(03)00167-3, 12892707.
17. Al-Mulla F, Keith WN, Pickford IR, Going JJ, Birnie GD. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer 1999, 24:306-314. 10.1002/(SICI)1098-2264(199904)24:4<306::AID-GCC3>3.0.CO;2-5, 10092128.
18. Bissig H, Richter J, Desper R, Meier V, Schraml P, Schaffer AA, Sauter G, Mihatsch MJ, Moch H. Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization. Am J Pathol 1999, 155:267-274. 10.1016/S0002-9440(10)65120-6, 1866676, 10393858.
19. Hovey RM, Chu L, Balazs M, DeVries S, Moore D, Sauter G, Carroll PR, Waldman FM. Genetic alterations in primary bladder cancers and their metastases. Cancer Res 1998, 58:3555-3560.
20. Kuukasjarvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, Isola J. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997, 57:1597-1604.
21. Pandis N, Teixeira MR, Adeyinka A, Rizou H, Bardi G, Mertens F, Andersen JA, Bondeson L, Sfikas K, Qvist H, Apostolikas N, Mitelman F, Heim S. Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients. Genes Chromosomes Cancer 1998, 22:122-129. 10.1002/(SICI)1098-2264(199806)22:2<122::AID-GCC6>3.0.CO;2-Z, 9598799.
22. Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, Payette T, Pistone M, Stecker K, Zhang BM, Zhou YX, Varnholt H, Smith B, Gadd M, Chatfield E, Kessler J, Baer TM, Erlander MG, Sgroi DC. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 2003, 100:5974-5979. 10.1073/pnas.0931261100, 156311, 12714683.
23. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature 2000, 406:747-752. 10.1038/35021093, 10963602.
24. Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, Richardson A, Cooper A, Strausberg R, Riggins GJ, Schnitt S, Gabrielson E, Gelman R, Polyak K. Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res 2003, 1:362-375.
25. Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein TJ, Kaufmann M, Diebold J, Arnholdt H, Muller P, Bischoff J, Harich D, Schlimok G, Riethmuller G, Eils R, Klein CA. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 2003, 100:7737-7742. 10.1073/pnas.1331931100, 164657, 12808139.
26. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmuller G, Klein CA. Systemic spread is an early step in breast cancer. Cancer Cell 2008, 13:58-68. 10.1016/j.ccr.2007.12.003, 18167340.
27. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401. 10.1038/nature03128, 15549107.
28. Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif 2003, 36(Suppl 1):59-72. 10.1046/j.1365-2184.36.s.1.6.x, 14521516.
29. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 1992, 255:1137-1141. 10.1126/science.1372131, 1372131.
30. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454. 10.1038/nrc822, 12189386.
31. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449:557-563. 10.1038/nature06188, 17914389.
32. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715. 10.1016/j.cell.2008.03.027, 2728032, 18485877.
33. Hurt EM, Farrar WL. Cancer stem cells: the seeds of metastasis?. Mol Interv 2008, 8:140-142. 10.1124/mi.8.3.7, 18693193.
34. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003, 3:921-930. 10.1038/nrc1231, 14737122.
35. Lu X, Kang Y. Discovery of bone metastasis genes by functional genomics. PharmDD 2005, 5:32-35.
36. Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H, Shipley JM, Senior RM, Shibuya M. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2002, 2:289-300. 10.1016/S1535-6108(02)00153-8, 12398893.
37. Kaplan RN, Rafii S, Lyden D. Preparing the "soil": the premetastatic niche. Cancer Res 2006, 66:11089-11093. 10.1158/0008-5472.CAN-06-2407, 2952469, 17145848.
38. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549. 10.1016/S1535-6108(03)00132-6, 12842083.
39. Kakiuchi S, Daigo Y, Tsunoda T, Yano S, Sone S, Nakamura Y. Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice. Mol Cancer Res 2003, 1:485-499.
40. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524. 10.1038/nature03799, 1283098, 16049480.
41. Ramaswamy S. Cancer transcriptomics: modeling metastasis. Eur J Hum Genet 2006, 14:1-2.
42. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874. 10.1073/pnas.191367098, 58566, 11553815.
43. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002, 347:1999-2009. 10.1056/NEJMoa021967, 12490681.
44. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003, 33:49-54. 10.1038/ng1060, 12469122.
45. Bernards R, Weinberg RA. A progression puzzle. Nature 2002, 418:823. 10.1038/418823a, 12192390.
46. Hunter K, Welch DR, Liu ET. Genetic background is an important determinant of metastatic potential. Nat Genet 2003, 34:23-24. author reply 25, 10.1038/ng0503-23b, 12721549.
47. Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, Ratajczak J, Ratajczak MZ. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005, 23:879-894. 10.1634/stemcells.2004-0342, 15888687.
48. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56. 10.1038/35065016, 11242036.
49. Hunter KW, Crawford NP, Alsarraj J. Mechanisms of metastasis. Breast Cancer Res 2008, 10(Suppl 1):S2. 10.1186/bcr1988, 2605099, 19091006.
50. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005, 17:548-558. 10.1016/j.ceb.2005.08.001, 16098727.
51. Stupack DG, Teitz T, Potter MD, Mikolon D, Houghton PJ, Kidd VJ, Lahti JM, Cheresh DA. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 2006, 439:95-99. 10.1038/nature04323, 16397500.
52. Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C, Gomis RR, Manova-Todorova K, Massague J. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 2007, 446:765-770. 10.1038/nature05760, 17429393.
53. Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Richardson A, Violette S, Nikolskaya T, Nikolsky Y, Bauerlein EL, Hahn WC, Gelman RS, Allred C, Bissell MJ, Schnitt S, Polyak K. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008, 13:394-406. 10.1016/j.ccr.2008.03.007, 18455123.
54. Riethmuller G, Klein CA. Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients. Semin Cancer Biol 2001, 11:307-311. 10.1006/scbi.2001.0386, 11513566.
55. Harris JF, Chambers AF, Hill RP, Ling V. Metastatic variants are generated spontaneously at a high rate in mouse KHT tumor. Proc Natl Acad Sci USA 1982, 79:5547-5551. 10.1073/pnas.79.18.5547, 346941, 6957880.
56. Ling V, Chambers AF, Harris JF, Hill RP. Dynamic heterogeneity and metastasis. J Cell Physiol Suppl 1984, 3:99-103. 10.1002/jcp.1041210412, 6589232.
57. Weiss L. Metastatic inefficiency. Adv Cancer Res 1990, 54:159-211. full_text, 1688681.
58. Pawelek JM. Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol 2005, 6:988-993. 10.1016/S1470-2045(05)70466-6, 16321767.
59. Pawelek JM. Cancer-cell fusion with migratory bone-marrow-derived cells as an explanation for metastasis: new therapeutic paradigms. Future Oncol 2008, 4:449-452. 10.2217/14796694.4.4.449, 18684055.
60. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 2005, 5:899-904. 10.1038/nrc1740, 16327766.
61. De Baetselier P, Roos E, Brys L, Remels L, Feldman M. Generation of invasive and metastatic variants of a non-metastatic T-cell lymphoma by in vivo fusion with normal host cells. Int J Cancer 1984, 34:731-738. 10.1002/ijc.2910340522, 6334039.
62. Miller FR, Mohamed AN, McEachern D. Production of a more aggressive tumor cell variant by spontaneous fusion of two mouse tumor subpopulations. Cancer Res 1989, 49:4316-4321.
63. Goldenberg DM, Pavia RA, Tsao MC. In vivo hybridisation of human tumour and normal hamster cells. Nature 1974, 250:649-651. 10.1038/250649a0, 4859359.
64. Chakraborty AK, Sodi S, Rachkovsky M, Kolesnikova N, Platt JT, Bolognia JL, Pawelek JM. A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids. Cancer Res 2000, 60:2512-2519.
65. Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, Morton CC, Klagsbrun M. Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res 2004, 64:8249-8255. 10.1158/0008-5472.CAN-04-1567, 15548691.
66. Espina V, Dettloff KA, Cowherd S, Petricoin EF, Liotta LA. Use of proteomic analysis to monitor responses to biological therapies. Expert Opin Biol Ther 2004, 4:83-93. 10.1517/14712598.4.1.83, 14680471.
67. Wang JW, Peng SY, Li JT, Wang Y, Zhang ZP, Cheng Y, Cheng DQ, Weng WH, Wu XS, Fei XZ, Quan ZW, Li JY, Li SG, Liu YB. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett 2009, 281:71-81. 10.1016/j.canlet.2009.02.020, 19299076.
68. Chen CD, Wang CS, Huang YH, Chien KY, Liang Y, Chen WJ, Lin KH. Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance. Proteomics 2007, 7:155-167. 10.1002/pmic.200600663, 17154271.
69. Tian T, Hao J, Xu A, Luo C, Liu C, Huang L, Xiao X, He D. Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci 2007, 98:1265-1274. 10.1111/j.1349-7006.2007.00514.x, 17537172.
70. Song HY, Liu YK, Feng JT, Cui JF, Dai Z, Zhang LJ, Feng JX, Shen HL, Tang ZY. Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol 2006, 132:92-98. 10.1007/s00432-005-0044-x, 16261346.
71. Wang G, Wang X, Wang S, Song H, Sun H, Yuan W, Cao B, Bai J, Fu S. Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues. Int J Colorectal Dis 2008, 23:675-682. 10.1007/s00384-008-0464-6, 18340452.
72. Pang J, Liu WP, Liu XP, Li LY, Fang YQ, Sun QP, Liu SJ, Li MT, Su ZL, Gao X. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis. J Proteome Res 9:216-226. 10.1021/pr900953s, 19894759.
73. Adamson J, Morgan EA, Beesley C, Mei Y, Foster CS, Fujii H, Rudland PS, Smith PH, Ke Y. High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity. Oncogene 2003, 22:2739-2749. 10.1038/sj.onc.1206341, 12743598.
74. Jing C, Beesley C, Foster CS, Chen H, Rudland PS, West DC, Fujii H, Smith PH, Ke Y. Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells. Cancer Res 2001, 61:4357-4364.
75. Yao H, Zhang Z, Xiao Z, Chen Y, Li C, Zhang P, Li M, Liu Y, Guan Y, Yu Y, Chen Z. Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Lung Cancer 2009, 65:41-48. 10.1016/j.lungcan.2008.10.024, 19058872.
76. Cheng L, Zhou L, Tao L, Zhang M, Cui J, Li Y. SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis. J Cancer Res Clin Oncol 2008, 134:769-776. 10.1007/s00432-007-0344-4, 18202856.
77. Zheng GX, Wang CX, Qu X, Deng XM, Deng BP, Zhang J. Establishment of serum protein pattern for screening colorectal cancer using SELDI-TOF-MS. Exp Oncol 2006, 28:282-287.
78. Zheng Z, Gao Y, Gu L, Mou H, Zhu C, Zhu J, Xu S. Discovery of metastasis-associated biomarkers in ovarian cancer using SELDI-TOF: An in vitro and clinical study. Clin Oncol Cancer Res 2009, 6:317-321.
79. SongWei D, XiaoMin W, LiYun L, JiFu L, ShanShan W, LingYun H, XueYuan X, DaCheng H. Discovery and identification of Serum Amyloid A protein elevated in lung cancer serum. Sci China C Life Sci 2007, 50:305-311. 10.1007/s11427-007-0053-x, 17609886.
80. Kohli M, Siegel E, Bhattacharya S, Khan MA, Shah R, Suva LJ. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) for determining prognosis in advanced stage hormone relapsing prostate cancer. Cancer Biomarkers 2007, 2:249-258.
81. Brozkova K, Budinska E, Bouchal P, Hernychova L, Knoflickova D, Valik D, Vyzula R, Vojtesek B, Nenutil R. Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression. Breast Cancer Res 2008, 10:R48. 2481497, 18510725.
82. Lu HB, Zhou JH, Ma YY, Lu HL, Tang YL, Zhang QY, Zhao CH. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer. Jpn J Clin Oncol 40:336-342. 10.1093/jjco/hyp175, 20089528.
83. Goncalves A, Esterni B, Bertucci F, Sauvan R, Chabannon C, Cubizolles M, Bardou VJ, Houvenaegel G, Jacquemier J, Granjeaud S, Meng XY, Fung ET, Birnbaum D, Maraninchi D, Viens P, Borg JP. Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy. Oncogene 2006, 25:981-989. 10.1038/sj.onc.1209131, 16186794.
84. Cowherd SM, Espina VA, Petricoin EF, Liotta LA. Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays. Clin Breast Cancer 2004, 5:385-392. 10.3816/CBC.2004.n.046, 15585078.
85. Sheehan KM, Calvert VS, Kay EW, Lu Y, Fishman D, Espina V, Aquino J, Speer R, Araujo R, Mills GB, Liotta LA, Petricoin EF, Wulfkuhle JD. Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol Cell Proteomics 2005, 4:346-355. 10.1074/mcp.T500003-MCP200, 15671044.
86. Paweletz CP, Charboneau L, Bichsel VE, Simone NL, Chen T, Gillespie JW, Emmert-Buck MR, Roth MJ, Petricoin IE, Liotta LA. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001, 20:1981-1989. 10.1038/sj.onc.1204265, 11360182.
87. Nishizuka S. Profiling cancer stem cells using protein array technology. Eur J Cancer 2006, 42:1273-1282. 10.1016/j.ejca.2006.01.042, 16644205.
88. Tibes R, Qiu Y, Lu Y, Hennessy B, Andreeff M, Mills GB, Kornblau SM. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol Cancer Ther 2006, 5:2512-2521. 10.1158/1535-7163.MCT-06-0334, 17041095.
89. Ota J, Yamashita Y, Okawa K, Kisanuki H, Fujiwara S, Ishikawa M, Lim Choi Y, Ueno S, Ohki R, Koinuma K, Wada T, Compton D, Kadoya T, Mano H. Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders. Oncogene 2003, 22:5720-5728. 10.1038/sj.onc.1206855, 12944923.
90. Dai L, Li C, Shedden KA, Lee CJ, Quoc H, Simeone DM, Lubman DM. Quantitative proteomic profiling studies of pancreatic cancer stem cells. J Proteome Res 9:3394-3402. 10.1021/pr100231m, 20486718.
91. He J, Liu Y, Xie X, Zhu T, Soules M, DiMeco F, Vescovi AL, Fan X, Lubman DM. Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach. J Proteome Res 9:2565-2572. 10.1021/pr100012p, 20235609.
92. Nomura DK, Dix MM, Cravatt BF. Activity-based protein profiling for biochemical pathway discovery in cancer. Nat Rev Cancer 10:630-638. 10.1038/nrc2901, 20703252.
93. Paulick MG, Bogyo M. Application of activity-based probes to the study of enzymes involved in cancer progression. Curr Opin Genet Dev 2008, 18:97-106. 10.1016/j.gde.2007.12.001, 2474457, 18294838.
94. Walls C, Zhou B, Zhang ZY. Activity-based protein profiling of protein tyrosine phosphatases. Methods Mol Biol 2009, 519:417-429. full_text, 2797542, 19381599.
95. Jessani N, Liu Y, Humphrey M, Cravatt BF. Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc Natl Acad Sci USA 2002, 99:10335-10340. 10.1073/pnas.162187599, 124915, 12149457.
96. Vinayavekhin N, Homan EA, Saghatelian A. Exploring disease through metabolomics. ACS Chem Biol 5:91-103. 10.1021/cb900271r, 20020774.
97. Chiang KP, Niessen S, Saghatelian A, Cravatt BF. An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. Chem Biol 2006, 13:1041-1050. 10.1016/j.chembiol.2006.08.008, 17052608.
98. Wang J, Zhang S, Li Z, Yang J, Huang C, Liang R, Liu Z, Zhou R. (1)H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis. Tumour Biol 2010, 32:223-231. 10.1007/s13277-010-0116-7, 20890798.
99. Lu X, Bennet B, Mu E, Rabinowitz J, Kang Y. Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model. J Biol Chem 285:9317-9321. 10.1074/jbc.C110.104448, 20139083.
100. Catchpole G, Platzer A, Weikert C, Kempkensteffen C, Johannsen M, Krause H, Jung K, Miller K, Willmitzer L, Selbig J, Weikert S. Metabolic profiling reveals key metabolic features of renal cell carcinoma. J Cell Mol Med 2009, 15:109-118.
101. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457:910-914. 10.1038/nature07762, 2724746, 19212411.